6:30 p.m. |
|
Other Seminars
Hope for Eczema: New Treatment Developments
Therapeutic Updates and Patient Dialogue
Emma Guttman, M.D., Ph.D., director, Center for Excellence in Eczema, Icahn School of Medicine at Mount Sinai Medical Center, Changing the Landscape of Eczema Therapeutics James Krueger, M.D., Ph.D., director, Milstein Medical Research Program, Laboratory of Investigative Dermatology, The Rockefeller University, What Eczema Can Learn from Psoriasis Daniela Velasco, eczema patent and trial participant, New Eczema Developments and Why Patients Need to Participate in Clinical Trials Mark Lebwohl, M.D., professor and chair, department of dermatology, Icahn School of Medicine at Mount Sinai Medical Center, How Patient Advocacy and Awareness Impact New Therapeutic Development Julie Block, CEO and president, National Eczema Association, Leaders in Eczema: Road to a Better Future
|
3:45 p.m. |
|
Friday Lecture Series
Immunity and the Microbiota in Health and Disease
Richard A. Flavell, Ph.D., FRS, Sterling Professor of Immunobiology and chair, department of immunobiology, Yale University School of Medicine; investigator, Howard Hughes Medical Institute
|